2025 annual financial data
Cellectar Biosciences 2025 Operating margin
Cellectar Biosciences 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -22,979,844 USD and net income was -21,791,037 USD.
Operating cash flow was -23,118,217 USD.
Get free Cellectar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,979,844 USD
- Net income
- -21,791,037 USD
- Operating cash flow
- -23,118,217 USD